Evidence map›Paper›PMID 40594441›Full record

ArticleScientific reports2025

GENOMICON-Seq enables realistic simulation of amplicon and exome sequencing for low-frequency mutation detection.

Milan S Stosic, Jean-Marc Costanzi, Ole Herman Ambur, Trine B Rounge

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. bronko: ultrafast, alignment-free detection of viral genome variation.bioRxiv : the preprint server for biology · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Milan S StosicDepartment of Life Sciences and Health, Faculty of Health Sciences, Oslo Metropolitan University-OsloMet, Oslo, Norway. milan.stosic@ahus.no.
Jean-Marc CostanziCancer Registry of Norway, Norwegian Institute of Public Health, Oslo, Norway.
Ole Herman AmburDepartment of Life Sciences and Health, Faculty of Health Sciences, Oslo Metropolitan University-OsloMet, Oslo, Norway.
Trine B RoungeCancer Registry of Norway, Norwegian Institute of Public Health, Oslo, Norway. t.b.rounge@farmasi.uio.no.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Accurate detection of low-frequency mutations is crucial for understanding viral evolution and tumorigenesis in humans, but is often confounded by technical artifacts introduced during library preparation and sequencing. We present GENOMICON-Seq, an end-to-end simulation tool that models both amplicon and whole exome sequencing (WES) workflows with realistic biological mutations and technical noise. GENOMICON-Seq inserts ground truth mutations, ranging from APOBEC3-like edits to COSMIC single base substitution signatures, before subjecting samples to simulated PCR errors, probe-capture enrichment, and Illumina-specific sequencing biases. By tracking each mutation's origin (true or error-derived), researchers can pinpoint detection limits and optimize variant-calling thresholds. We illustrate GENOMICON-Seq's versatility through study cases involving human papillomavirus (HPV) amplicon sequencing, highlighting the impacts of polymerase fidelity, viral copy number, and read depth on detecting low-frequency mutations. In parallel, WES simulations demonstrate how capture biases and varying allele frequencies affect somatic mutation calls. GENOMICON-Seq is thus a flexible, reproducible framework for assessing new protocols, benchmarking variant callers, and refining data analysis pipelines, ultimately reducing costly trial-and-error in the laboratory. The Docker-based package is freely available at https://github.com/Rounge-lab/GENOMICON-Seq .

Indexed as

ExomeExome SequencingHigh-Throughput Nucleotide SequencingMutationSoftwareComputer SimulationHumansAmplicon sequencingIntrahost single nucleotide variants (iSNVs)SimulationSingle base substitution (SBS) mutational signatureSomatic mutationsWhole exome sequencing (WES)

Identifiers

PMID40594441
PMCPMC12216740

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.